DiFUSION To Mitigate Surgical Site Infections That Affect An Estimated 780,000 Patients In The USA Each Year
DiFUSION Technologies, Inc., a medical device company targeting the orthopaedic market, today announced its corporate launch. The company will focus on reducing the rising incidence of Surgical Site Infections (SSIs) in spinal surgeries.
Tags: antibiotic resistant bacteria, bone growth, cases result, degenerative disorders, disorders of the cervical spine, gary ghiselli, geck, genetic [...]
